Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response (MENTOR)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2013 by Chonnam National University Hospital.
Recruitment status was  Recruiting
Roche Pharma AG
Information provided by (Responsible Party):
Young-Chul Kim, Chonnam National University Hospital Identifier:
First received: January 5, 2012
Last updated: January 30, 2013
Last verified: January 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)